Base de dados : LILACS
Pesquisa : D03.383.663.283.446 [Categoria DeCS]
Referências encontradas : 84 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 9 ir para página                      

  1 / 84 LILACS  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-459260
Autor: Veiga Junior, Valdir F; Andrade Junior, Martinho A; Ferraz, Isolde D. K; Christo, Herick B; Pinto, Angelo C.
Título: Constituintes das sementes de Copaifera officinalis L / Constituents from Copaifera officinalis L. seeds
Fonte: Acta amaz;37(1):123-126, 2007.
Idioma: pt.
Resumo: O gênero Copaifera L. é um dos mais importantes economicamente na Região Amazônica devido, principalmente, à produção dos óleos de copaíba, oléo-resinas com diversas propriedades farmacológicas confirmadas. Apesar disso, os estudos fitoquímicos com as sementes das árvores do gênero Copaifera L.são raros. Copaifera officinalis foi a primeira espécie do gênero Copaifera a ser descrita. Este trabalho descreve a composição dos extratos obtidos em hexano e em acetato de etila das sementes de C. officinalis. No extrato obtido em hexano, a análise por cromatografia em fase gasosa utilizando padrões e através de espectrometria de massas permitiu a identificação de: esqualeno, tetradecano, hexadecano, campesterol, estigmasterol e beta-sitosterol; os ácidos graxos hexadecanóico, 9-octadecenóico e octadecanóico (majoritários); e decanóico, eicosanóico, docosanóico e tetracosanóico (minoritários). Cumarina foi isolada do extrato em acetato de etila e identificada por técnicas de RMN.

Copaifera L. is one of the most economically important plant genera in the Amazon Region, since it exudes a resin-oil named copaiba oil possessing several confirmed pharmacological properties. In spite of that, phytochemical studies of the seeds from this genus are rare. Copaifera officinalis L. was the first species in the genus Copaifera to be described. This paper describes the chemical composition of the hexane and ethyl acetate extracts of the seeds from this species. In the hexane extract, gas chromatography and mass spectrometry analyses enabled us to identify squalene, tetradecane, hexadecane, campesterol, stigmasterol and beta-sitosterol; hexadecanoic, 9-octadecenoic and octadecanoic acids (major substances); as well as decanoic, eicosanoic, docosanoic and tetracosanoic (minor substances) acids. Coumarin was detected in the ethyl acetate extract, isolated and identified by NMR.
Descritores: Cumarínicos
Ácidos Graxos
Fabaceae
Responsável: BR6.1 - BCS - Biblioteca de Ciências da Saúde


  2 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Cuba
Texto completo
Id: lil-740921
Autor: Rodríguez Chanfrau, Jorge Enrique; Rodríguez Ferrada, Carlos.
Título: Influencia del tiempo de cosecha sobre el contenido de cumarina y de umbeliferon hallado en los extractos de Justicia pectoralis Jacq. (tilo) / Harvest time influences on coumarin and umbelliferone contents in extracts of Justicia pectoralis Jacq. (tilo)
Fonte: Rev. cuba. farm;48(3), jul.-set. 2014. tab, Ilus.
Idioma: en.
Resumo: INTRODUCTION: Justicia pectoralis Jacq. (Acanthaceae) is medicinal plant species commonly used in Cuba for the treatment of nervous disorders because of its sedative effect. Coumarin is one of its main active phytochemicals present in the extracts obtained from this plant and used as analytic marker in quality control. On the other hand, this compound contributes to the sedative effect attributed to this plant. OBJECTIVE: to evaluate the influence of harvest time on the coumarin and umbelliferone (7-hydroxycoumarin) in Justicia pectoralis extracts. METHODS: the experiment lasted two years. The harvest was performed at 4, 6 and 8 months after planting. Aqueous and hydroalcohol extracts were produced and the coumarin and umbelliferone contents were determined by high resolution liquid chromatography. RESULTS: the achieved results showed the presence of coumarin and umbelliferone in both extracts. Both methods can be used for the extraction of these components from the plant, although in the case of umbelliferone, the best extraction results were achieved by using aqueous extract. In both cases, the recovery percentages were more than 98 percent. This study confirmed that the harvest time significantly influences on the coumarin and umbelliferone contents. CONCLUSIONS: the best results are observed in the first two harvests (4 and 6 months at summer time), which indicates that the industry should process the vegetal material in these two periods of the year(AU)

INTRODUCCIÓN: Justicia pectoralis Jacq. (Acanthaceae) es una planta medicinal comúnmente usada en Cuba para el tratamiento de enfermedades nerviosas por su efecto sedante. La cumarina es uno de los fitocomponentes mayoritarios en los extractos obtenidos con esta planta y empleado como marcador analítico en los controles de calidad. Por otro lado, este componente contribuye con el efecto sedante atribuido a esta planta. OBJETIVO: evaluar la influencia del tiempo de cosecha sobre el contenido de cumarina y umbelliferona (7 hidroxicumarina) en extractos de Justicia pectoralis. MÉTODOS: se desarrolló el experimento durante 2 años. Se realizaron las cosechas a los 4, 6 y 8 meses de plantada. Se elaboraron extractos acuosos e hidroalcohólicos y se determinó el contenido de cumarina y umbelliferone por cromatografía líquida de alta resolución. RESULTADOS: se mostró la presencia de cumarina y umbelliferona en ambos extractos. Además, en el caso de la umbelliferona, los mejores resultados se alcanzaron al aplicar extracción acuosa. En ambos casos, los por cientos de recobrados fueron superiores al 98 por ciento. Se confirmó que el tiempo de cosecha influyó significativamente sobre el contenido de cumarina y umbelliferona. CONCLUSIONES: los mejores resultados se obtienen en la primeras dos cosechas (4 y 6 meses que coincide con el verano), lo que sugiere que el material de la planta debe procesarse por la industria en esos periodos del año(AU)
Descritores: Umbeliferonas/farmacologia
Cumarínicos/farmacologia
-Cuba
Tilia
Responsável: CU1.1 - Biblioteca Médica Nacional


  3 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-570419
Autor: Abreu, Viviane Gomes da Costa; Silva, Marilda Conceição da; Magalhães, Rozângela Manfrini; Piló-Veloso, Dorila; Xavier, Izelene Felício da Silva; Oliveira, Patrícia Machado; Alcântra, Antônio Flávio de Carvalho.
Título: Chemical constituents from the stem of Brosimum potabile (Moraceae) / Constituintes químicos do cerne de Brosimum potabile (Moraceae)
Fonte: Acta amaz;40(4):711-718, dez. 2010. ilus, tab.
Idioma: en.
Resumo: Three coumarins, 5-methoxypsoralene, xanthyletin, and (-)-marmesin, have been isolated from the ethanolic extract of the stem of the Amazonian plant Brosimum potabile. The structures were determined on the basis of NMR analyses and by comparison with spectroscopic data in the literature. The analysis of the hexane fractions by GC-MS in EIMS mode suggested the presence of (1-methylpentyl)-benzene; α,α-dimethyl-4-(1-methylethyl)-benzenemethanol; 1-methyl-3,5-bis(1-methylethyl)-benzene; urs-12-ene; chola-5,22-dien-3β-ol; cholesta-4,6-dien-3β-ol; sitosteryl 9(Z)-octadecenoate; cholesta-5,22-dien-3β-ol; cholesta-4,6,22-trien-3-one; and cholesta-4,22-dien-3-one. NMR data of other hexane fractions indicated the presence of 3β-acetoxy-lup-12,20(29)-diene; 3β-acetoxy-olean-12-ene; 3β-acetoxy-urs-12-ene; and adian-5-ene. All these compounds are first described in B. potabile.

Três cumarinas, 5-metoxipsoraleno, xantiletina e (-)-marmesina, foram isoladas no extrato etanólico do cerne da planta amazônica Brosimum potabile. Suas estruturas foram determinadas a partir das análises por RMN e por comparação com dados espectroscópicos da literatura. As análises das frações hexânicas por CG/EM sugeriram a presença de (1-metilpentil)-benzeno; α,α-dimetil-4-(1-metiletil)-benzenometanol; 1-metil-3,5-bis(1-metiletil)-benzeno; urs-12-eno; cola-5,22-dien-3β-ol; colesta-4,6-dien-3β-ol; (9Z)-octadecenoato de sitosterila; colesta-5,22-dien-3β-ol; colesta-4,6,22-trien-3-ona e colesta-4,22-dien-3-ona. Dados de RMN de outras frações hexânicas indicaram a presença de 3β-acetóxi-lup-12,20(29)-dieno; 3β-acetóxi-olean-12-eno; 3β-acetóxi-urs-12-eno e adian-5-eno. Todos esses compostos foram identificados pela primeira vez em B. potabile.
Descritores: Cumarínicos
Moraceae
Triterpenos Pentacíclicos
Responsável: BR6.1 - BCS - Biblioteca de Ciências da Saúde


  4 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Id: lil-289493
Autor: Carranza, E.
Título: La hemostasia en cirugía dermatológica / The hemostasia in surgery dermatológica
Fonte: Folia dermatol. peru;11(1):36-40, abr. 2000. tab.
Idioma: es.
Descritores: Heparina/efeitos adversos
Aspirina/efeitos adversos
Cumarínicos/efeitos adversos
Dermatologia
Hemorragia/cirurgia
Hemostasia Cirúrgica
Limites: Humanos
Responsável: PE1.1 - Oficina Universitária de Biblioteca


  5 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: lil-512196
Autor: Souza, Denise Heleno de; Yamamoto, Célia Hitomi; Pinho, José de Jesus Ribeiro Gomes; Alves, Maria Silvana; Araújo, Aílson da Luz André de; Sousa, Orlando Vieira de.
Título: Atividade antibacteriana frente ao Streptococcus mutans e estabilidade de produtos naturais contendo extrato de Mikania glomerata Sprengel / Antibacterial activity against Streptococcus mutans and stability of the natural products containing extract from Mikania glomerata Sprengel
Fonte: HU rev;32(1), 10/04/2006.
Idioma: pt.
Resumo: Mikania glomerata Sprengel (Asteraceae), conhecida como guaco, é usada popularmente como broncodilatador, antiasmático e expectorante, cujos efeitos são atribuídos à presença de cumarinas. O presente estudo avaliou o efeito de extratos e formulações (soluções antissépticase xaropes) contendo guaco, com ou sem própolis, sobre o crescimento de S. mutans e a estabilidade das soluções anti-sépticas. A atividade antibacteriana dos extratos e formulações sobre S. mutans ATCC 25175 foi realizada pelo método de difusão em ágar e, posteriormente, através da aplicação desse mesmo procedimento, determinou-se a estabilidade das soluções anti-sépticas submetidas à temperatura ambiente e sob refrigeração (8ºC - 10ºC), mensalmente, por um período de três meses. Os extratos de guaco e de própolis e as soluções anti-sépticas inibiram o crescimento de S. mutans. No primeiro mês, com exceção da soluçãoanti-séptica com guaco 5%, todas as demais inibiram o crescimento do microrganismo testado. No segundo mês, somente as soluções anti-sépticas contendo própolis produziram inibição bacteriana. Após três meses de armazenamento, as soluções contendo própolis, em temperatura ambiente, foram ativas e estáveis. Os resultados mostram que formulações contendo guaco, com ou sem própolis, foram ativas sobre S. mutans, mas podem perder a estabilidade em decorrência da temperatura. No entanto, estes achados demonstram que os produtos naturais podem ser uma alternativa importante no combate à formação da cárie e placa dentária.

Mikania glomerata Sprengel (Asteraceae), known as guaco, is commonly used as bronchodilator, antiasthmatic, and expectorant, and the effects observed are attributed to coumarin. The aim of the present study was to evaluate the effect of the extracts and formulations (antiseptic solutions and syrup) containing guaco, with or without propolis, against Streptococcus mutans, and the stability of the antiseptic solutions. The antibacterial activity of the extracts and the formulations against S. mutans ATCC 25175 was assessed by agar diffusion, with the same procedure being used to determine the stability of the antiseptic solutions under room temperature and refrigeration (8º - 10ºC) during a period of three months. The extracts containing guaco and propolis and the antiseptic solutions inhibited the growth of S. mutans. After the first month, except for the antiseptic solution with guaco 5%, all of them inhibited the microorganism tested. In the second month, only the antiseptic solution containing propolis produced the bacterial inhibition. In the last month, under room temperature, the solutions with propolis were active and stable. The results showed that the formulations containing guaco, with or without propolis, were active against S. mutans, but could lose stability depending on temperature. However, this report emonstrated that natural products could be an important alternative against oral infections, including tooth decay and dental plaque.
Descritores: Própole
Streptococcus mutans
Mikania
Antibacterianos
-Broncodilatadores
Antiasmáticos
Asteraceae
Cumarínicos
Expectorantes
Anti-Infecciosos Locais
Tipo de Publ: Relatos de Casos
Responsável: BR378.1 - Biblioteca Central


  6 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-889115
Autor: Qiu, Zhenpeng; Zhou, Junxuan; Zhang, Cong; Cheng, Ye; Hu, Junjie; Zheng, Guohua.
Título: Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2. 2. 15 cells by targeting Lin28a/let-7a axis
Fonte: Braz. j. med. biol. res = Rev. bras. pesqui. méd. biol;51(7):e7220, 2018. tab, graf.
Idioma: en.
Projeto: Hubei Provincial Department of Education.
Resumo: An abnormality in the Lin28/let-7a axis is relevant to the progression of hepatitis B virus (HBV)-positive hepatocellular carcinoma (HCC), which could be a novel therapeutic target for this malignant tumor. The present study aimed to investigate the antiproliferative and anti-invasive effects of urolithin A in a stable full-length HBV gene integrated cell line HepG2.2.15 using CCK-8 and transwell assays. The RNA and protein expressions of targets were assessed by quantitative PCR and western blot, respectively. Results revealed that urolithin A induced cytotoxicity in HepG2.2.15 cells, which was accompanied by the cleavage of caspase-3 protein and down-regulation of Bcl-2/Bax ratio. Moreover, urolithin A suppressed the protein expressions of Sp-1, Lin28a, and Zcchc11, and elevated the expression of microRNA let-7a. Importantly, urolithin A also regulated the Lin28a/let-7a axis in transient HBx-transfected HCC HepG2 cells. Furthermore, urolithin A decelerated the HepG2.2.15 cell invasion, which was involved in suppressing the let-7a downstream factors HMGA2 and K-ras. These findings indicated that urolithin A exerted the antiproliferative effect by regulating the Lin28a/let-7a axis and may be a potential supplement for HBV-infected HCC therapy.
Descritores: Proteínas de Ligação a RNA/efeitos dos fármacos
Carcinoma Hepatocelular/tratamento farmacológico
Cumarínicos/farmacologia
MicroRNAs/efeitos dos fármacos
Neoplasias Hepáticas/tratamento farmacológico
-Valores de Referência
Sincalida/análise
Fatores de Tempo
Replicação Viral/efeitos dos fármacos
Sobrevivência Celular/efeitos dos fármacos
Western Blotting
Reprodutibilidade dos Testes
Análise de Variância
Proteínas de Ligação a RNA/análise
Carcinoma Hepatocelular/genética
Carcinoma Hepatocelular/virologia
MicroRNAs/análise
Proliferação de Células/efeitos dos fármacos
Células Hep G2
Reação em Cadeia da Polimerase em Tempo Real
Neoplasias Hepáticas/genética
Neoplasias Hepáticas/virologia
Limites: Humanos
Responsável: BR1.1 - BIREME


  7 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Texto completo
Id: biblio-1001583
Autor: El-Sharkawy, Karam Ahmed; AlBratty, Mohammed Mofreh; Alhazmi, Hassan Ahmad.
Título: Synthesis of some novel pyrimidine, thiophene, coumarin, pyridine and pyrrole derivatives and their biological evaluation as analgesic, antipyretic and anti-inflammatory agents
Fonte: Braz. J. Pharm. Sci. (Online);54(4):e00153, 2018. tab, graf.
Idioma: en.
Resumo: Pyrimidine derivative 3 was afforded through the reaction of compound (1) with 5-ureidohydantion (2). Product 3 underwent a cyclization to produce fused pyrimidine derivative 7, although the latter product 7 was synthesized through one step via the reaction of compound (1) with 5-ureidohydantion (2) using another catalyst. Compound 3 was oriented to react with cyclic ketones 8a,b in the presence of elemental sulfur, salicylaldehyde (10), aryldiazonium chlorides 12a,b and ω-bromo-4-methoxy- acetophenone (14), which afforded, fused thiophene derivatives 9a,b, coumarin derivative 11, arylhdrazono derivatives 13a,b and 4-methoxyphenyl butenyl derivative 15, respectively. The latter product 15 was reacted with either potassium cyanide (16a) or potassium thiocyanide (16b) to form cyano and thiocyano derivatives 17a,b, respectively. Compound 17a underwent further cyclization to afford pyridopyrimidine derivative 19. Compound 15 was reacted with either hydrazine (20a) or phenylhydrazine (20b) to produce hydrazo derivatives 21a,b and these products were cyclize to produce pyrrole derivatives 23a,b. Finally, 5-ureidohydantion (2) was reacted with compounds 24a,b,c to afford pyrimidine derivatives 25a,b,c. The structures of the synthesized compounds were confirmed using IR, 1H NMR, 13C NMR and mass spectrometry techniques. Compounds 11 and 19 have promising as analgesic and antipyretic activities
Descritores: Piridinas/análise
Pirimidinas/agonistas
Pirróis
Tiofenos/análise
Cumarínicos/análise
-Antipiréticos
Analgésicos/classificação
Responsável: BR40.1 - DBD - Divisão de Biblioteca e Documentacão do Conjunto das Químicas


  8 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Simöes, Cláudia Maria Oliveira
Texto completo
Texto completo
Id: biblio-839460
Autor: Cárdenas, Paola Andrea; Kratz, Jadel Müller; Hernández, Aura; Costa, Geison Modesti; Ospina, Luis Fernando; Baena, Yolima; Simões, Cláudia Maria Oliveira; Jimenez-Kairuz, Álvaro; Aragon, Marcela.
Título: In vitro intestinal permeability studies, pharmacokinetics and tissue distribution of 6-methylcoumarin after oral and intraperitoneal administration in Wistar rats
Fonte: Braz. J. Pharm. Sci. (Online);53(1):e16081, 2017. tab, graf.
Idioma: en.
Projeto: CAPES.
Resumo: ABSTRACT 6-Methylcoumarin (6MC) is a semisynthetic coumarin with important in vitro and in vivo anti-inflammatory activity. In order to continue the pre-clinical characterization of this molecule, in vitro intestinal permeability, plasma profile and tissue distribution after oral administration in rats were studied. The permeability of 6MC was evaluated by the Caco-2 cellular model in both the apical-basal (A-B) and basal-apical (B-A) directions. The pharmacokinetics and biodistribution were evaluated in rats after oral and intraperitoneal administration at doses of 200 mg/kg. Transport experiments with Caco-2 cells showed that 6MC presented high permeability at all concentrations evaluated. This finding suggested that 6MC could be transported across the gut wall by passive diffusion. The plasma concentration-time curve showed that the maximum concentration (Cmax) was 17.13 ± 2.90 µg/mL at maximum time (Tmax) of 30 min for the oral route and Cmax 26.18 ± 2.47 µg/mL at 6.0 min for the intraperitoneal administration, with elimination constant of (Ke ) 0.0070 min-1 and a short life half time of (T1/2 ) lower that 120 min. The distribution study showed that 6MC has high accumulation in the liver, and widespread distribution in all the organs evaluated.
Descritores: Permeabilidade
Técnicas In Vitro/instrumentação
Administração Oral
Ratos Wistar/classificação
Cumarínicos/análise
-Farmacocinética
Absorção Peritoneal
Enteropatias/classificação
Limites: Animais
Masculino
Feminino
Ratos
Tipo de Publ: Técnicas In Vitro
Responsável: BR1.1 - BIREME


  9 / 84 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
Id: biblio-987181
Autor: García Zebadúa, Julio César; Reyes Chilpa, Ricardo.
Título: El árbol tropical Calophyllum brasiliense: una revisión botánica, química y farmacológica / The tropical tree Calophyllum brasiliense: a botanical, chemical and pharmacological review
Fonte: Vitae (Medellín);21(2):126-145, 2014. Ilustraciones.
Idioma: es.
Resumo: Antecedentes: Calophyllum brasiliense Cambess. Es un árbol de la familia Calophyllaceae, separada recientemente de Clusiaceae (Guttiferae). Se distribuye ampliamente en selvas tropicales lluviosas del continente americano, desde Brasil hasta México. Esta especie sintetiza diversos metabolitos secundarios en hojas, flores, frutos, corteza y raíz, tales como cumarinas, cromanonas, xantonas, terpenos, flavonoides y compuestos fenólicos, los cuales presentan múltiples propiedades biológicas. Objetivos: Ofrecer una visión general de las características botánicas, químicas y farmacológicas de C. brasiliense, así como evidencias químicas, anatómicas y genéticas que sugieren la existencia de quimiotipos (fenotipos químicos) en la especie. Métodos: Se revisó la información disponible en las bases de datos NCBI y SciFinder®, se seleccionaron investigaciones relevantes que permitieron conocer los compuestos químicos aislados y su actividad biológica. Resultados: Entre los compuestos sintetizados por C. brasiliense destacan calanólidos e inofilums, especialmente el (+)-calanólido A, como inhibidores potentes de la enzima transcriptasa reversa del virus de inmunodeficiencia humana tipo 1 (VIH-1) y baja toxicidad a linfocitos humanos. El (+)-calanólido A, una dipiranocumarina tetracíclica, podría ser el primer fármaco de origen natural aprobado por la FDA (EUA) en el tratamiento del VIH/SIDA. Otros compuestos, tales como cumarinas tipo mammea, cromanonas, xantonas y triterpenos, mostraron actividad contra protozoarios, células tumorales humanas, como bactericidas y antiespasmódicos. La actividad más importante de cumarinas tipo mammea es contra protozoarios como Leishmania y Trypanosoma. En relación a L. amazonensis, destacó (-)-mammea A/BB presentando buena actividad y selectividad contra amastigotes y promastigotes, y baja toxicidad en macrófagos humanos. La (-)-mammea A/BA, y las xantonas preniladas mostraron alta citotoxicidad sobre líneas celulares tumorales humanas y T. cruzi. Las evidencias químicas, anatómicas y genéticas indican que existen quimiotipos en C. brasiliense, sugiriendo un proceso de especiación en curso en el taxón. Las secuencias ribosomales (ITS) discriminaron al quimiotipo 1 (produce coumarinas tipo mammea) de los quimiotipos 2 y 3 (biosintetizan calanólidos e inofilums), siendo útiles como posibles códigos de barras. Conclusiones: El adecuado manejo de C. brasiliense mediante técnicas silvícolas y biotecnológicas, así como el conocimiento científico y tecnológico, podrían aportar soluciones a países en desarrollo, por ejemplo mediante producción de fitomedicamentos, a enfermedades como el VIH/ SIDA, Leshmaniasis y la Enfermedad de Chagas.

Rationale: Calophyllum brasiliense Cambess. Is a tree belonging to Calophyllaceae family, recently separated from Clusiaceae (= Guttiferae). This species is widely distributed in the Tropical Rain Forests of the American continent, from Brazil to Mexico. It synthesizes a wide variety of secondary metabolites isolated from leaves, flowers, fruits, bark and roots, such as coumarins, chromanones, xanthones, terpenes,flavonoids and phenolic compounds, which exhibit multiple biological properites. Objective: To provide a comprehensive view of the botanical, chemical and pharmacological characteristics of C. brasiliense, and to present chemical, anatomical and genetic evidences supporting the notion of chemotypes (chemical phenotypes) in this species. Methods: Information available in the databases NCBI and SciFinder® was reviewed, and relevant investigations were selected regarding to chemical compounds isolated and their biological activity. Results: Among compounds synthesized by C. brasiliense, calanolides and inophyllums stand out, specially (+)-calanolide A, since these can inhibit reverse transcriptase of human immunodeficiency virus type 1 (HIV-1). (+)-Calanolide A, a tetracyclic dipyranocoumarin, could be the first drug of natural origin approved by the FDA (US) in the treatment of HIV/AIDS. Other compounds, such as mammea type-coumarins, chromanones, xanthones, and triterpenes showed antitumor, antiparasitic, antibacterial and antispasmodic activity. Most important activity of mammea type-coumarins is against protozoa, such as Leishmania, and Trypanosoma. Regarding to L. amazonensis, (-)-mammea A/BB stands out, being highly potent and selective against amastigotes, and promastigotes, but poorly toxic to human macrophages. (-)-Mammea A/BA as well as prenylated xanthones showed high citotoxicity against human tumor cell lines and T. cruzi. The chemical, anatomical and genetical evidences supported the idea of chemotypes in C. brasiliense, suggesting a current process of speciation in this taxon. The ribosomal ITS sequences discriminate chemotype 1 (produces mammea type coumarins) from chemotypes 2 and 3(synthesize calanolides and inophyllums) being useful like possible barcodes. Conclusions: The proper management of Calophyllum brasiliense with forestry and biotechnological methods, as well as scientific and technological knowledge, could provide solutions to developing countries, for instance through the production of phytomedicines against HIV/AIDS, and illnesses caused by protozoa such as Leshmaniasis and Chaga's Disease.
Descritores: HIV
-Botânica
Leishmaniose
Cumarínicos
Xantonas
Limites: Humanos
Tipo de Publ: Artigo Clássico
Responsável: CO56.3 - Biblioteca


  10 / 84 LILACS  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Chile
Texto completo
Id: biblio-899662
Autor: Nazar J, Claudio; Cárdenas C, Antonia; Coloma D, Roberto; Contreras C, José Ignacio; Molina, Ian; Miranda H, Pablo; Fuentes H, Ricardo.
Título: Manejo perioperatorio de pacientes con tratamiento anticoagulante crónico / Perioperative management of patients with chronic anticoagulant therapy
Fonte: Rev. chil. cir;70(1):84-91, 2018. tab, ilus.
Idioma: es.
Resumo: Resumen La terapia anticoagulante es ampliamente utilizada en la práctica clínica, como profilaxis en pacientes con riesgo de presentar fenómenos tromboembólicos o como tratamiento en aquellos que han presentado algún evento trombótico. Cada vez es más frecuente enfrentarse a pacientes en tratamiento anticoagulante crónico que serán intervenidos mediante procedimientos quirúrgicos, por lo que es importante y necesario conocer el manejo perioperatorio de los diferentes fármacos anticoagulantes, para disminuir los riesgos y complicaciones asociados a la suspensión o mantención de estos en el período perioperatorio. Para lograr este objetivo se debe evaluar y balancear el riesgo de sangrado versus el riesgo de eventos tromboembólicos, considerando la condición médica de cada paciente y el tipo de procedimiento quirúrgico que recibirá. La recomendación para fármacos anticoagulantes orales antagonistas de vitamina K es mantenerlos en cirugías con bajo riesgo de sangrado y suspenderlos 5 días antes de procedimientos quirúrgicos con riesgo hemorrágico moderado y alto, controlando el international normalized ratio el día previo a la cirugía. Los nuevos anticoagulantes orales no requieren monitorización de rutina, recomendándose suspenderlos a las 24-96 h previas al procedimiento quirúrgico, dependiendo del riesgo hemorrágico de cada cirugía y de la función renal. En relación con los anticoagulantes parenterales, la heparina no fraccionada en infusión intravenosa se recomienda suspenderla 4-5 h antes de la cirugía, mientras que la utilizada vía subcutánea, 12 h previas a la intervención quirúrgica. Las heparinas de bajo peso molecular en dosis de tratamiento se sugiere descontinuarlas 24 h previas a la cirugía, mientras que las usadas en dosis profilácticas, solo 12 h antes.

Anticoagulant therapy is widely used in clinical practice, as prophylaxis in patients at risk of presenting thromboembolic phenomena or as treatment in those who have presented a thrombotic event. It is increasingly the number of patients on chronic anticoagulant therapy to undergo surgical procedures, so it is important and necessary to know the perioperative management of the different anticoagulant drugs to reduce the risks and complications associated with suspension or maintenance of these in the perioperative period. To achieve this goal, the risk of bleeding should be evaluated and balanced against the risk of thromboembolic events, considering the medical condition of each patient and the type of surgical procedure to which they have undergone. The recommendation for vitamin K antagonist oral anticoagulant drugs is to maintain them for surgeries at low risk of bleeding and to suspend them 5 days before surgical procedures with moderate and high bleeding risk, controlling 'International Normalized Ratio' the day before surgery. The new oral anticoagulants do not require routine monitoring, recommending suspending them 24-96 h prior to the surgical procedure, depending on the hemorrhagic risk of each surgery and renal function of patient. In relation to parenteral anticoagulants, unfractionated heparin in intravenous infusion is recommended to be discontinued 4-5 h prior to surgery, while the subcutaneous route, 12 h prior to surgery. Low-molecular-weight heparins in treatment doses should be suspended 24 h prior to surgery, while in prophylactic doses, only 12 h earlier.
Descritores: Assistência Perioperatória/métodos
Anticoagulantes/administração & dosagem
-Complicações Pós-Operatórias/prevenção & controle
Vitamina K/antagonistas & inibidores
Heparina/administração & dosagem
Administração Oral
Medição de Risco
Cumarínicos/administração & dosagem
Inibidores do Fator Xa/administração & dosagem
Hemorragia/prevenção & controle
Limites: Humanos
Tipo de Publ: Revisão
Responsável: CL61.1 - Biblioteca Central Campus Sur



página 1 de 9 ir para página                      
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde